As anticipated, FDA has approved the next generation Eversense 180-day continuous glucose monitoring (CGM) system from Senseonics. This approval is one of many big milestone activities expected in the diabetes management space in 2022.
https://i0.wp.com/mtgelectronics.com/wp-content/uploads/2022/02/shutterstock_105421997.jpg?fit=1000%2C667&ssl=1 667 1000 admin https://mtgelectronics.com/wp-content/uploads/2021/03/MTG-logo-for-site-300x100-1.png admin2022-02-14 09:40:162022-02-14 09:41:44Diabetes Tech Is Having Its Best Year Yet
- New Smart Syringe Uses NFC to Store Drug InformationMay 6, 2022 - 12:13 pm
- New Scale DK-M3-LS-U2-8 Linear Smart Stage Developer’s Kits are now Available!March 31, 2022 - 6:55 pm
- For EMS Providers, Success Lies in Managing Components Across the Board March 25, 2022 - 7:10 am
- US Electronics Reshoring Plan Risks Missing the BoatMarch 24, 2022 - 10:07 am